Alveo Financial Tower

Alveo Technologies Announces Major Distribution Expansion Across EMEA

Retrieved on: 
Wednesday, December 13, 2023
Farm, Disease, Growth, COVID-19, Partnership, Diagnosis, Alveo Financial Tower

ALAMEDA, Calif., Dec. 13, 2023 /PRNewswire/ -- Alveo Technologies, Inc., a leader in molecular sensing and diagnostics with its proprietary technology platform, today announced 19 new distributor partnerships across Europe, Africa, and the Middle East (EMEA). These new partnerships expand its global reach to support Alveo's 2024 product launches and to fulfill demand for its current COVID-19 product already on the market.

Key Points: 
  • Alveo's be.well™ COVID-19 Test is currently available in the EU and many other countries in the EMEA region.
  • The company is also developing additional tests for human pathogens and partnering with agriscience companies to develop tests for agricultural use cases.
  • "These new partnerships will enable us to accelerate our momentum in EMEA and meet the rapidly growing demand for our molecular tests," said Erik Tyrrell-Knott, chief business & strategy officer at Alveo.
  • With these new partnerships in place, Alveo is expanding its global presence and positioning the company for rapid growth as it releases tests for additional use cases.

ALVEO TECHNOLOGIES AND CORTEVA AGRISCIENCE COLLABORATE TO ADVANCE MOLECULAR CROP DISEASE DIAGNOSTICS AND IMPROVE CROP YIELDS

Retrieved on: 
Tuesday, October 24, 2023
Farmer, Pandemic, Google Cloud Connect, Cartridge, Infection, Diagnosis, Analyser, Partnership, R, Alveo Financial Tower, Medical imaging, Medical device, Corteva

ALAMEDA, Calif., Oct. 24, 2023 /PRNewswire/ -- Alveo Technologies, Inc. today announced a collaboration with Corteva Agriscience to expand the offering of its novel eco-friendly molecular sensing and disease diagnostics technology to include a first-in-field agricultural disease diagnostic.

Key Points: 
  • ALAMEDA, Calif., Oct. 24, 2023 /PRNewswire/ -- Alveo Technologies, Inc. today announced a collaboration with Corteva Agriscience to expand the offering of its novel eco-friendly molecular sensing and disease diagnostics technology to include a first-in-field agricultural disease diagnostic.
  • Alveo has developed a rapid, handheld, portable medical-grade platform that pairs advanced molecular assays with cloud-enabled data analytics for real-time disease, pathogen analysis, and diagnosis.
  • Using this highly sensitive multiplexed molecular testing platform, Corteva scientists aim to design crop-specific assays to detect pathogens in the field.
  • This collaboration reflects both companies' open-source philosophy and desire to build together across sectors and technologies.

AMD Unveils Purpose-Built, FPGA-Based Accelerator for Ultra-Low Latency Electronic Trading

Retrieved on: 
Friday, September 29, 2023
Virtex, Marketing, AMD, DSP, HF, IP, Proteus Design Suite, Alveo Financial Tower, Alpha Data, Algorithm, PyTorch, AI, Ecosystem, ORION, ADA, FPGA, Software, Computer data storage, Cryptocurrency

LONDON, Sept. 29, 2023 /PRNewswire/ -- AMD (NASDAQ: AMD) today announced the AMD Alveo™ UL3524 accelerator card, a new fintech accelerator designed for ultra-low latency electronic trading applications. Already deployed by leading trading firms and enabling multiple solution partner offerings, the Alveo UL3524 provides proprietary traders, market makers, hedge funds, brokerages, and exchanges with a state-of-the-art FPGA platform for electronic trading at nanosecond (ns) speed.

Key Points: 
  • — Solution partners Alpha Data, Exegy and Hypertec add to growing ecosystem of ultra-low latency solutions for fintech market —
    LONDON, Sept. 29, 2023 /PRNewswire/ -- AMD (NASDAQ: AMD) today announced the AMD Alveo™ UL3524 accelerator card , a new fintech accelerator designed for ultra-low latency electronic trading applications.
  • "In ultra-low latency trading, a nanosecond can determine the difference between a profitable or losing trade," said Hamid Salehi, director of product marketing at AMD.
  • The AMD Virtex™ UltraScale+ VU2P FPGA powering the Alveo UL3524 accelerator card is enabling ultra-low latency appliances from Alpha Data.
  • "The new Virtex UltraScale+ FPGA from AMD brings a step change to ultra-low latency trading and networking," said David Miller, managing director of Alpha Data.

AMD Unveils Purpose-Built, FPGA-Based Accelerator for Ultra-Low Latency Electronic Trading

Retrieved on: 
Friday, September 29, 2023
Virtex, Marketing, AMD, DSP, HF, IP, Proteus Design Suite, Alveo Financial Tower, Alpha Data, Algorithm, PyTorch, AI, Ecosystem, ORION, ADA, FPGA, Software, Computer data storage, Cryptocurrency

LONDON, Sept. 29, 2023 /PRNewswire/ -- AMD (NASDAQ: AMD) today announced the AMD Alveo™ UL3524 accelerator card, a new fintech accelerator designed for ultra-low latency electronic trading applications. Already deployed by leading trading firms and enabling multiple solution partner offerings, the Alveo UL3524 provides proprietary traders, market makers, hedge funds, brokerages, and exchanges with a state-of-the-art FPGA platform for electronic trading at nanosecond (ns) speed.

Key Points: 
  • — Solution partners Alpha Data, Exegy and Hypertec add to growing ecosystem of ultra-low latency solutions for fintech market —
    LONDON, Sept. 29, 2023 /PRNewswire/ -- AMD (NASDAQ: AMD) today announced the AMD Alveo™ UL3524 accelerator card , a new fintech accelerator designed for ultra-low latency electronic trading applications.
  • "In ultra-low latency trading, a nanosecond can determine the difference between a profitable or losing trade," said Hamid Salehi, director of product marketing at AMD.
  • The AMD Virtex™ UltraScale+ VU2P FPGA powering the Alveo UL3524 accelerator card is enabling ultra-low latency appliances from Alpha Data.
  • "The new Virtex UltraScale+ FPGA from AMD brings a step change to ultra-low latency trading and networking," said David Miller, managing director of Alpha Data.

AMD Unveils Purpose-Built, FPGA-Based Accelerator for Ultra-Low Latency Electronic Trading

Retrieved on: 
Wednesday, September 27, 2023
Virtex, Marketing, AMD, DSP, HF, IP, Proteus Design Suite, Alveo Financial Tower, Alpha Data, Algorithm, PyTorch, AI, Ecosystem, ORION, ADA, FPGA, Software, Computer data storage, Cryptocurrency

SANTA CLARA, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today announced the AMD Alveo™ UL3524 accelerator card, a new fintech accelerator designed for ultra-low latency electronic trading applications. Already deployed by leading trading firms and enabling multiple solution partner offerings, the Alveo UL3524 provides proprietary traders, market makers, hedge funds, brokerages, and exchanges with a state-of-the-art FPGA platform for electronic trading at nanosecond (ns) speed.

Key Points: 
  • — Solution partners Alpha Data, Exegy and Hypertec add to growing ecosystem of ultra-low latency solutions for fintech market —
    SANTA CLARA, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today announced the AMD Alveo™ UL3524 accelerator card , a new fintech accelerator designed for ultra-low latency electronic trading applications.
  • “In ultra-low latency trading, a nanosecond can determine the difference between a profitable or losing trade,” said Hamid Salehi, director of product marketing at AMD.
  • The AMD Virtex™ UltraScale+ VU2P FPGA powering the Alveo UL3524 accelerator card is enabling ultra-low latency appliances from Alpha Data.
  • "The new Virtex UltraScale+ FPGA from AMD brings a step change to ultra-low latency trading and networking,” said David Miller, managing director of Alpha Data.

Alveo Technologies Announces Partner Program and Portal, New Enablement Software Suite, Further Empowering Partners in Co-Development of Advanced Molecular Diagnostics

Retrieved on: 
Tuesday, July 11, 2023
Software, Research, Other Health, Professional Services, Technology, Agriculture, Natural Resources, Data Analytics, Science, Veterinary, Biotechnology, Health, Other Science, Partnership, Food, Fraunhofer Society, Cell therapy, Infection, Medicine, LAMP, Sanitation, Water, Diagnosis, Immunology, Development corporation, Asylum Support Partnership, Food security, Farm, Fine chemical, Medical device, Alveo Financial Tower

Furthermore, its newest partnership with the Fraunhofer Institute for Cell Therapy and Immunology IZI extends the platform into the large animal veterinary sector.

Key Points: 
  • Furthermore, its newest partnership with the Fraunhofer Institute for Cell Therapy and Immunology IZI extends the platform into the large animal veterinary sector.
  • Alveo has developed a rapid, handheld, reusable, and rugged multiplexed platform that pairs advanced molecular assays with cloud-enabled data analytics for highly accurate and sensitive real-time disease, pathogen and contaminant detection, analysis, and diagnosis.
  • It utilizes Alveo’s globally patented loop-mediated isothermal amplification (LAMP) method for the direct electrical sensing of nucleic acid amplification.
  • The Partnership Portal facilitates collaboration and gives partners access to all research, training, and development resources required to bring a molecular diagnostic to market.

AMD Launches First 5nm ASIC-based Media Accelerator Card to Power New Era of Interactive Media Services at Scale

Retrieved on: 
Thursday, April 6, 2023
Acceleration, NAB, North Hall, VPU, ASIC, AMD, Overalls, VMAF, 32X, Alveo Financial Tower, Motion, CPU, SDK, Architecture, GStreamer, AV1, AI, FFmpeg, ROI, Execute Direct Access Program, Software, Video game, Computer data storage

SANTA CLARA, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today announced the AMD Alveo™ MA35D media accelerator featuring two 5nm, ASIC-based video processing units (VPUs) supporting the AV1 compression standard and purpose-built to power a new era of live interactive streaming services at scale.

Key Points: 
  • SANTA CLARA, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today announced the AMD Alveo™ MA35D media accelerator featuring two 5nm, ASIC-based video processing units (VPUs) supporting the AV1 compression standard and purpose-built to power a new era of live interactive streaming services at scale.
  • The Alveo MA35D media accelerator delivers the high channel density, with up to 32x 1080p60 streams per card, power efficiency and ultra-low-latency performance critical to reducing the skyrocketing infrastructure costs now required for scaling such compute intensive content delivery.
  • Scaling high-volume streaming services requires maximizing the number of channels per server while minimizing power and bandwidth-per-stream.
  • Check out the Alveo MA35D in the AMD booth at NAB, North Hall N2158

Wowza Collaborates with AMD for Greener Video Streaming

Retrieved on: 
Tuesday, April 4, 2023
Technology, Environment, Audio, Video, Green Technology, Software, Internet, Product management, NAB, CDN, AMD, SOC, Government, VOD, SOC 2, Alveo Financial Tower, Video game, Wowza Streaming Engine

Wowza, a leader in live video and video-on-demand (VOD) streaming for over 6,000 businesses worldwide, extends its relationship with AMD with the development of a cutting-edge, high-density, and more eco-friendly live video streaming option.

Key Points: 
  • Wowza, a leader in live video and video-on-demand (VOD) streaming for over 6,000 businesses worldwide, extends its relationship with AMD with the development of a cutting-edge, high-density, and more eco-friendly live video streaming option.
  • Wowza has integrated AMD’s video transcoding platform featuring the Alveo U30 Media Accelerator Card and the Video SDK into its Wowza Streaming Engine software.
  • “AMD and Wowza collaborated to bring support for the popular and easy to use Wowza Streaming Engine software on the Alveo U30 media accelerator.
  • AMD, the AMD logo, Alveo, and combinations thereof are trademarks of Advanced Micro Devices, Inc.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20230404005401/en/

Alveo Technologies Announces ISO 13485:2016 Certification

Retrieved on: 
Tuesday, March 21, 2023
Technology, Medical Devices, General Health, Infectious Diseases, Other Natural Resources, Veterinary, FDA, Agriculture, Natural Resources, COVID-19, Wearables, Mobile Technology, Health, Health Technology, Other Technology, Other Health, Hardware, Data Management, IVDR, QMS, ISO, Aquaculture, Infection, COVID-19 testing, Quality, Certification, GMED, European, IVD, Diagnosis, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, International Organization for Standardization, Farm, Medical device, EU, Alveo Financial Tower

Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics with its proprietary be.well™ technology platform, today announced its quality management system (QMS) has achieved ISO 13485:2016 certification for the design, development and manufacture of in vitro diagnostic kits and analyzers for the detection of infectious disease.

Key Points: 
  • Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics with its proprietary be.well™ technology platform, today announced its quality management system (QMS) has achieved ISO 13485:2016 certification for the design, development and manufacture of in vitro diagnostic kits and analyzers for the detection of infectious disease.
  • Compliance with the ISO 13485 standard is required for companies to market medical devices in many markets, including the European Union, Canada, Japan, and Australia.
  • In addition, the U.S. Food and Drug Administration has announced plans to harmonize its existing medical device QMS requirements with ISO 13485, proposing new regulations that incorporate ISO 13485 as the foundational requirements.
  • “We are thrilled to achieve ISO 13485 certification,” says Alveo CEO Shaun Holt.

Alveo Technologies and Government of Barbados Collaborate to Co-Develop Advanced Molecular Disease Diagnostics Across Multiple End Markets

Retrieved on: 
Thursday, January 5, 2023
Technology, Biotechnology, Mobile, Wireless, Health, Wearables, Mobile Technology, Biometrics, Other Health, Professional Services, Infectious Diseases, General Health, Data Analytics, Health Technology, Hardware, Data Management, Government, Agriculture, Development corporation, Ecosystem, Partnership, Biotechnology, IP, Ministry, Infection, MOU, COVID-19, Laboratory, Government of Barbados, Food, Growth, Medicine, Diagnosis, Lac, Pharmaceutical industry, Science, Alveo Financial Tower

Alveo has developed a rapid, handheld, portable, and eco-friendly platform that pairs advanced molecular assays with cloud-enabled data analytics for real-time disease, pathogen and contaminant detection, analysis, and diagnosis at point of need.

Key Points: 
  • Alveo has developed a rapid, handheld, portable, and eco-friendly platform that pairs advanced molecular assays with cloud-enabled data analytics for real-time disease, pathogen and contaminant detection, analysis, and diagnosis at point of need.
  • Export Barbados (BIDC) is the agency of the Government of Barbados with specific responsibility for promoting and facilitating industrial and export development and sits under the umbrella of the Ministry of Industry, Innovation, Science and Technology.
  • As part of its mandate Export Barbados (BIDC) also has responsibility for advancing the life sciences industry of Barbados.
  • “We are pleased to partner with Alveo Technologies and explore new applications for this exciting molecular diagnostic technology in the life sciences.”